Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfda.gov
What's New: Drugs RSS Feed
Get the latest updates from What's New: Drugs RSS Feed directly as they happen.
Follow now 153 followers
Latest posts
Last updated about 2 hours ago
2020_02 Test Article EDITED FT 01
about 11 hours ago
2020_02 Test Article some long description some long description.
FDA approves the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors
about 11 hours ago
FDA approved Ayvakit (avapritinib) for the treatment of adults with unresectable or...
FDA approves new treatment for adults with migraine
about 11 hours ago
FDA approves Ubrelvy (ubrogepant) tablets for the acute treatment of migraine with...
First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response
about 11 hours ago
FDA announced today the approval of Ervebo, the first FDA-approved vaccine for...
Trump Administration takes historic steps to lower U.S. prescription drug prices
about 11 hours ago
The Trump Administration is taking steps to lower prescription drug prices by...
FDA approves use of drug to reduce risk of cardiovascular events in certain adult patient groups
about 11 hours ago
FDA expands the indication of Vascepa (icosapent ethyl) capsules to reduce the...
FDA underscores that consumers should not use drugs, dietary supplements and devices recalled from Basic Reset and Biogenyx following consent decree for federal violations
about 11 hours ago
The U.S. Food and Drug Administration is alerting consumers of a recall...
FDA approves first generics of Gilenya
about 11 hours ago
The U.S. Food and Drug Administration today approved three applications for first...
FDA launches app for health care professionals to report novel uses of existing medicines for patients with difficult-to-treat infectious diseases
about 11 hours ago
FDA launches app for health care professionals to report novel uses of...
FDA approves novel treatment to target abnormality in sickle cell disease
about 11 hours ago
FDA granted accelerated approval to Oxbryta (voxelotor) for the treatment of sickle...
Statement from Sarah Yim, M.D., acting director of the Office of Therapeutic Biologics and Biosimilars in the FDA’s Center for Drug Evaluation and Research, on FDA’s continued progress facilitating competition in the biologic marketplace with approval
about 11 hours ago
FDA has taken another step to further foster biologics competition with the...
FDA approves new antibacterial drug to treat complicated urinary tract infections as part of ongoing efforts to address antimicrobial resistance
about 11 hours ago
The FDA today approved Fetroja (cefiderocol), an antibacterial drug for treatment of...